RTI Surgical, Inc. (NASDAQ:RTIX) issued its earnings results on Thursday. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.01, Bloomberg Earnings reports. RTI Surgical had a positive return on equity of 2.07% and a negative net margin of 6.53%. The business had revenue of $66.69 million during the quarter, compared to analysts’ expectations of $65.63 million. The firm’s revenue was up .2% on a year-over-year basis. RTI Surgical updated its FY17 guidance to $0.05-0.07 EPS.

A number of equities analysts have recently issued reports on the company. BidaskClub cut RTI Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, August 8th. Zacks Investment Research raised RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, October 13th.

TRADEMARK VIOLATION NOTICE: This article was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2017/11/02/rti-surgical-inc-rtix-releases-earnings-results-meets-estimates.html.

In related news, EVP John N. Varela purchased 12,000 shares of the business’s stock in a transaction that occurred on Friday, August 11th. The stock was acquired at an average cost of $4.85 per share, for a total transaction of $58,200.00. Following the completion of the purchase, the executive vice president now owns 47,998 shares in the company, valued at approximately $232,790.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Nicholas J. Valeriani purchased 5,500 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The stock was bought at an average price of $4.70 per share, with a total value of $25,850.00. Following the completion of the purchase, the director now owns 47,754 shares of the company’s stock, valued at approximately $224,443.80. The disclosure for this purchase can be found here. Insiders own 4.90% of the company’s stock.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Earnings History for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.